Literature DB >> 7943034

Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase.

S S Chong1, E E Eichler, D L Nelson, M R Hughes.   

Abstract

We report on a method for ethidium bromide detection of FMR1 normal and premutation-size CGG triplet repeats. A set of PCR conditions has been optimized for the polymerase of the hyperthermophilic bacterium, Pyrococcus furiosus. Using this protocol, normal-size alleles ranging from 5 to 50 repeats, as well as most of premutation-size alleles, varying from > 50 to approximately 200 repeats, could be detected by ethidium bromide staining of agarose gels. Since the protocol requires neither autoradiography nor polyacrylamide gel electrophoresis, it promises to provide a rapid means for the exclusion of fragile X syndrome in males with mental retardation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943034     DOI: 10.1002/ajmg.1320510447

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  20 in total

1.  Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population.

Authors:  D C Crawford; C E Schwartz; K L Meadows; J L Newman; L F Taft; C Gunter; W T Brown; N J Carpenter; P N Howard-Peebles; K G Monaghan; S L Nolin; A L Reiss; G L Feldman; E M Rohlfs; S T Warren; S L Sherman
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Archaeal dUTPase enhances PCR amplifications with archaeal DNA polymerases by preventing dUTP incorporation.

Authors:  Holly H Hogrefe; Connie J Hansen; Bradley R Scott; Kirk B Nielson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  Optimal conditions to use Pfu exo(-) DNA polymerase for highly efficient ligation-mediated polymerase chain reaction protocols.

Authors:  M Angers; J F Cloutier; A Castonguay; R Drouin
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

4.  No evidence for significant association between GABA receptor genes in chromosome 15q11-q13 and autism in a Japanese population.

Authors:  Mamoru Tochigi; Chieko Kato; Shinko Koishi; Yuki Kawakubo; Kenji Yamamoto; Hideo Matsumoto; Ohiko Hashimoto; Soo-Yung Kim; Keiichiro Watanabe; Yukiko Kano; Eiji Nanba; Nobumasa Kato; Tsukasa Sasaki
Journal:  J Hum Genet       Date:  2007-10-24       Impact factor: 3.172

5.  RS46(DXS548) genotyping of reproductive cells: approaching preimplantation testing of the fragile-X syndrome.

Authors:  J C Dreesen; J P Geraedts; J C Dumoulin; J L Evers; M H Pieters
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

6.  FMR1 in global populations.

Authors:  C B Kunst; C Zerylnick; L Karickhoff; E Eichler; J Bullard; M Chalifoux; J J Holden; A Torroni; D L Nelson; S T Warren
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Construction, Expression, and Characterization of Recombinant Pfu DNA Polymerase in Escherichia coli.

Authors:  Wenjun Zheng; Qingsong Wang; Qun Bi
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

Review 8.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

9.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

10.  Consensus characterization of 16 FMR1 reference materials: a consortium study.

Authors:  Jean Amos Wilson; Victoria M Pratt; Amit Phansalkar; Kasinathan Muralidharan; W Edward Highsmith; Jeanne C Beck; Scott Bridgeman; Ebony M Courtney; Lidia Epp; Andrea Ferreira-Gonzalez; Nick L Hjelm; Leonard M Holtegaard; Mohamed A Jama; John P Jakupciak; Monique A Johnson; Paul Labrousse; Elaine Lyon; Thomas W Prior; C Sue Richards; Kristy L Richie; Benjamin B Roa; Elizabeth M Rohlfs; Tina Sellers; Stephanie L Sherman; Karen A Siegrist; Lawrence M Silverman; Joanna Wiszniewska; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.